Read news on NEJM with our app.
Read more in the app
Low-cost MS treatment shown to be as effective as standard therapy in landmark NEJM trial - EurekAlert!
NEJM/ASCO: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma in landmark international trial - EurekAlert!
NEJM Group launches NEJM Clinician - EurekAlert!
Metachromatic Leukodystrophy (MLD) and gene therapy: a game-changing treatment backed by NEJM—Timing Is Everything - EurekAlert!
